Optinose delivery system hits primary goals in phase 3
To view this email as a web page, click here

Today's Rundown

Featured Story

Bottlenecks are slowing switch to GSK's long-acting HIV injectable Cabenuva: clinician

Supply bottlenecks linked to centralized distribution are slowing the pace at which patients are switching to GlaxoSmithKline’s long-acting HIV injectable Cabenuva, according to a U.S.-based expert clinician.

read more

Top Stories

NuCana's twist on chemo drug Gemzar fails in phase 3 again

NuCana’s retooled chemotherapy candidate Acelarin has come up short in phase 3 again. The latest failure wipes out hopes that NuCana’s attempt to improve on gemcitabine, sold by Eli Lilly as Gemzar, will drive improved outcomes in biliary cancer.

read more

And, exhale: Relief for Optinose as delivery system hits primary endpoints in chronic sinusitis phase 3

Optinose has chalked up a win for its exhalation delivery system in chronic sinusitis patients in a phase 3 clinical trial. Using the system to deliver fluticasone propionate sparked improvements in symptoms and an objective measure of disease in the sinus cavities, causing the study to hit its co-primary endpoints.

read more

Mass General plans study of nasally delivered binge eating disorder drug

Massachusetts General Hospital is preparing to trial Tonix Pharmaceuticals’ nasally delivered potentiated oxytocin TNX-1900 in the treatment of binge eating disorder. 

read more

The top 10 drugs losing US exclusivity in 2022

With AbbVie’s megablockbuster Humira set to face an onslaught of biosimilars next year, industry watchers have long circled 2023 as the year of the major pharma patent cliff. But this year’s slate of top losses of exclusivity covers a hefty slate of brands worth more than $17 billion in annual sales.  

read more

Resources

Whitepaper: The Long Game of Strategic Relationship Building with Medical Experts

Read why many MSLs are still challenged in developing integrated strategies to increase the volume of meaningful engagements. Download this industry report to find out what the top challenges are and suggestion strategies to solve them. Download now.

eBook: EMEA Regulatory Roadblocks around Decentralized Trials

Learn about ways to break down regulatory roadblocks and get closer to 100% clarity on regulatory positions to advance decentralized clinical trials in research.

Whitepaper: Top 5 Challenges Of Decentralized Clinical Trials And How To Overcome Them

How to overcome top challenges faced in decentralized trials.

Paid Marketplace: United Cargo: Providing comprehensive solutions for the most critical shipments

The United Cargo team has made a commitment to pharmaceutical and medical partners that we are equipped to support their vaccine transportation needs safely and effectively across our expansive global and domestic network. The safety and security of these commodities is our priority, and we are proud to be a trusted partner in these efforts. Download infographic now.

Whitepaper: Tailored, Dedicated Support Expedites COVID-19 Vaccine Trial

Sites receiving augmentation support enroll more than 30,000 patients in just over three months. See how additional site resources can make a difference.

Research: How Buffer Prep Services Alleviate Sudden Spikes in Campaign Volume

Learn how a CDMO partnered with Thermo Fisher Scientific to manage high-volume process liquid and buffer preparation scale-up. Download the free case study from Thermo Fisher Scientific

Whitepaper: QC for ex vivo manipulated cell lines and tissues

A variety of genetic analysis methods are valuable in ensuring that ex vivo human cells to be used for cell-based therapies are correctly identified, have the correct characteristics, and are free of contaminants.

Webinar: Using Next Best to Elevate your Omnichannel Marketing Strategy

Learn how to elevate your omnichannel marketing strategy with Next Best - a combination of data and analytics, deployed to facilitate decision making.

Webinar: The Faster Path From Pre-Filled Syringe to Auto-Injector

Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar.

Whitepaper: Formulation Strategies When Transitioning From Vial to PFS

Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care.

Whitepaper: Enhance the cost-effectiveness of your cGMP chemical supply chain

Learn how to develop a high-performing supply chain for cGMP chemicals used throughout your biologics workflow. Download the free whitepaper from Thermo Fisher Scientific

eBook: Get solutions to market faster

Read Get to Know Cloud Content Management for Life Sciences and learn how to eliminate silos across all workflows, from R&D to commercialization.

Events